PTCT Q4 2017 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PTCTPTC Therapeutics, Inc.

$5B

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$78M+209.8% YoY

Gross Profit

$76M96.9% margin

Operating Income

$5M7.0% margin

Net Income

$1M1.6% margin

EPS (Diluted)

$0.03

QoQ Revenue Growth

+86.4%

Cash Flow

Operating Cash Flow

$21M

Free Cash Flow

$19M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$392M

Total Liabilities

$235M

Stockholders' Equity

$156M

Cash & Equivalents

$191M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$78M	$25M	+209.8%
Gross Profit	$76M	-$20,000	+378080.0%
Operating Income	$5M	-$25M	+121.8%
Net Income	$1M	-$27M	+104.7%